InsiderTrades

Form 4 for TNDM TANDEM DIABETES CARE INC

Accepted 2021-08-31 00:00:00 ET · period of report 2021-08-27 · accession 0001438133-21-000147 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-08-31 2021-08-27 TNDM Sheridan John F Pres, CEO, Dir F - Tax $110.31 -407 6,610 -6% -$44.9K
D 2021-08-31 2021-08-27 TNDM Sheridan John F Pres, CEO, Dir M - OptEx $0.00 +820 7,017 +13% $0
D 2021-08-31 2021-08-27 TNDM Sheridan John F Pres, CEO, Dir M - OptEx $0.00 +820 9,017 +10% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-27 F D 407 $110.31 6,610 D — —
2 Common Common Stock 2021-08-27 M A 820 $0.00 7,017 D — —
3 Derivative Restricted Stock Unit 2021-08-27 M A 820 $0.00 9,017 D — · — to — 820 Common Stock (F2) Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). (F3) Each RSU represents a contingent right to receive one share of common stock of the Company. (F4) RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.